ZHEJIANG MEDICINE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.53 CNY | +0.42% |
|
+2.47% | -11.18% |
| Apr. 25 | Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 2023 | Zhejiang Medicine Wins Nod to Trial Digestive Acid Drug | MT |
Business Summary
Number of employees: 6,208
Sales per Business
| CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
Vitamin E
42.7
%
| 3,142 | 36.0 % | 3,450 | 42.7 % | +9.80% |
Social Delivery Series
26.5
%
| 2,276 | 26.1 % | 2,137 | 26.5 % | -6.11% |
Vitamin A
6.4
%
| 1,231 | 14.1 % | 514 | 6.4 % | -58.21% |
Other
5.9
%
| 41 | 0.5 % | 473 | 5.9 % | +1,044.52% |
Levofloxacin Series
4.8
%
| 627 | 7.2 % | 390 | 4.8 % | -37.83% |
Vancomycin Hydrochloride
4.7
%
| 361 | 4.1 % | 381 | 4.7 % | +5.71% |
Miglitol Series
2.9
%
| 214 | 2.5 % | 235 | 2.9 % | +9.63% |
Teicoplanin Series
2.2
%
| 220 | 2.5 % | 179 | 2.2 % | -18.53% |
Nerofloxacin Malate Series
2.2
%
| 110 | 1.3 % | 174 | 2.2 % | +57.36% |
Progesterone Series
1.2
%
| 104 | 1.2 % | 99 | 1.2 % | -4.98% |
Other Business
0.5
%
| - | - | 43 | 0.5 % | - |
Sales per region
| CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
China
66.2
%
| 5,874 | 64.6 % | 5,347 | 66.2 % | -8.97% |
Overseas
48.5
%
| 4,624 | 50.9 % | 3,912 | 48.5 % | -15.40% |
Inter-segment Offset
-14.7
%
| -1,411 | -15.5 % | -1,186 | -14.7 % | -15.89% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Chun Lei Lu
CEO | Chief Executive Officer | 57 | 06-05-31 |
Nan Xing Li
BRD | Director/Board Member | 38 | 15-06-10 |
Ke Qiu
IRC | Investor Relations Contact | - | - |
Wei Dong Ye
SEC | Corporate Secretary | 61 | 89-12-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chun Bo Li
CHM | Chairman | 65 | 97-04-30 |
Nai Wei Chen
BRD | Director/Board Member | 67 | 18-06-14 |
Chun Lei Lu
CEO | Chief Executive Officer | 57 | 06-05-31 |
Yong Cao
BRD | Director/Board Member | 54 | 09-09-28 |
Xiao Ming Wu
BRD | Director/Board Member | 69 | 21-12-14 |
Yi Zheng Qiu
BRD | Director/Board Member | 50 | 21-06-15 |
Yun Feng Liu
BRD | Director/Board Member | 55 | 21-06-15 |
Zhen Hua Chu
BRD | Director/Board Member | 42 | 21-06-15 |
Yu Qing Yu
BRD | Director/Board Member | 47 | 21-06-15 |
Hong Yu Cang
BRD | Director/Board Member | 41 | 23-06-05 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 964,975,000 | 565,549,504 ( 58.61 %) | 3,337,250 ( 0.3458 %) | 58.61 % |
Company contact information
Zhejiang Medicine Co., Ltd.
168 Zhiyuan Middle Avenue Binhai New City
312366, Shaoxing
+86 575 8521 1979
http://www.zmc.top
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
9.53
CNY
Average target price
13
CNY
Spread / Average Target
+36.41%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.18% | 1.26B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 600216 Stock
- Company Zhejiang Medicine Co., Ltd.
